Excessive insulin receptor serine phosphorylation in cultured fibroblasts and in skeletal muscle. A potential mechanism for insulin resistance in the polycystic ovary syndrome
Dunaif A., Xia J., Book C.B., Schenker E., and Tang Z. Excessive insulin receptor serine phosphorylation in cultured fibroblasts and in skeletal muscle. A potential mechanism for insulin resistance in the polycystic ovary syndrome. J Clin Invest 96 (1995) 801-810
Insulin resistance in the skeletal muscle of women with PCOS involves intrinsic and acquired defects in insulin signaling
Corbould A., Kim Y.B., Youngren J.F., Pender C., Kahn B.B., Lee A., and Dunaif A. Insulin resistance in the skeletal muscle of women with PCOS involves intrinsic and acquired defects in insulin signaling. Am J Physiol Endocrinol Metab 288 (2005) E1047-E1054
Decreased insulin receptor (IR) autophosphorylation in fibroblasts from patients with PCOS. effects of serine kinase inhibitors and IR activators
Li M., Youngren J.F., Dunaif A., Goldfine I.D., Maddux B.A., Zhang B.B., and Evans J.L. Decreased insulin receptor (IR) autophosphorylation in fibroblasts from patients with PCOS. effects of serine kinase inhibitors and IR activators. J Clin Endocrinol Metab 87 (2002) 4088-4093
Enhanced mitogenic signaling in skeletal muscle of women with polycystic ovary syndrome
Corbould A., Zhao H., Mirzoeva S., Aird F., and Dunaif A. Enhanced mitogenic signaling in skeletal muscle of women with polycystic ovary syndrome. Diabetes 55 (2006) 751-759
Evidence for a genetic basis for hyperandrogenemia in polycystic ovary syndrome
Legro R.S., Driscoll D., Strauss III J.F., Fox J., and Dunaif A. Evidence for a genetic basis for hyperandrogenemia in polycystic ovary syndrome. Proc Natl Acad Sci U S A 95 (1998) 14956-14960
Candidate gene region for polycystic ovary syndrome on chromosome 19p13.2
Urbanek M., Woodroffe A., Ewens K.G., DiamantiKandarakis E., Legro R.S., Strauss III J.F., et al. Candidate gene region for polycystic ovary syndrome on chromosome 19p13.2. J Clin Endocrinol Metab 90 (2005) 6623-6629